Clinical Trial - Trial ChiCTR2200061265
Access comprehensive clinical trial information for ChiCTR2200061265 through Pure Global AI's free database. This Phase 1 trial is sponsored by Shandong Cancer Hospital and is currently Not yet recruiting. The study focuses on Chronic Lymphocytic Leukemia.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
ChiCTR2200061265
Phase 1
Not yet recruiting
Trial Details
Chinese Clinical Trial Registry • ChiCTR2200061265
View on Chinese Clinical Trial Registry
Untitled Trial
A prospective multicenter clinical study of Zanubrutinib Followed Zanubrutinib Plus FCR in Newly Diagnosed Symptomatic CLL/SLL
Study Focus
Sponsor & Location
Shandong Cancer Hospital
self-financing
China
Timeline & Enrollment
Phase 1
N/A
May 01, 2024
ICD-10 Classifications
Chronic lymphocytic leukaemia of B-cell type
Chronic myelomonocytic leukaemia
Acute myelomonocytic leukaemia
Lymphoid leukaemia
Chronic leukaemia of unspecified cell type
Data Source
Chinese Clinical Trial Registry
ChiCTR2200061265
Non-Device Trial